Efectividad de un programa para la cesación tabáquica en pacientes hospitalizados por un síndrome coronario agudo

  1. Alba Saá, F. 1
  2. Sánchez Alonso, A. 1
  3. Rama Merchán, JC. 1
  4. Casado Romo, MA. 1
  5. Borrego Blanco, B. 1
  6. Del Campo Bujedo, F. 1
  1. 1 Hospital Universitario de Salamanca
    info

    Hospital Universitario de Salamanca

    Salamanca, España

    ROR https://ror.org/0131vfw26

Revista:
Revista Enfermería CyL

ISSN: 1989-3884

Ano de publicación: 2016

Volume: 8

Número: 2

Páxinas: 33-39

Tipo: Artigo

Outras publicacións en: Revista Enfermería CyL

Resumo

During hospitalization after an acute ischemic heart disease, it may be the ideal place for health education and to apply a multidisciplinary program of treatment of smoking time. It is intended to evaluate the effectiveness, short and long term, the program for smoking cessation in patients admitted to the service with an acute coronary syndrome. observational, longitudinal and prospective study that included all smokers consecutive patients admitted to the cardiology department for acute coronary syndrome from February 2010 to February 2012, and expressed their intention to quit is made. Through the complete history of smoking each patient, determination of serum cotinine levels at admission. Delivery of an informative guide developed by the Services of Cardiology and Pneumology, on the side effects of snuff and the benefits of quitting. Daily interview the patient in order to reinforce the benefits of the cessation of snuff and behavioral strategies referred to in the guide. Follow up with phone calls per month, 6 and 12 months and 3 months-face consultation. Data analysis using SPSS 15.0 software. 102 patients, 88 males (86.3%) were included, with a mean age of 53 ± 8 years. Autoreferido rates abandonment of snuff were 93% per month, 80% at 3 months, 83% at 6 months and 79% a year. At 3 months after discharge, 22 measurements of cotinine, of which 65% were negative were performed. A tobacco treatment program with direct intervention (minimum council), may be useful in controlling the modifiable cardiovascular risk factor, thereby achieving reducing the likelihood of new coronary events.

Referencias bibliográficas

  • Carrión F, Maya M, Brotons B, Marín J. Patología relacionada con el tabaquismo. Viure en Salut 1998; 40: 11-3.
  • Pardell H, Saltó E, Salleras Ll. Manual de diagnóstico y tratamiento del tabaquismo. Madrid: Panamericana, 1996; 45-71.
  • Nebot Tost, M; Manual de Enfermería. Prevención y rehabilitación cardíaca . AEEC 2009; 52-54.
  • Jiménez Ruiz, CA y cols. “Normativa para el tratamiento del tabaquismo de la Sociedad Española de Neumología y Cirugía Torácica”. Arch Bronconeumol 1999; 35: 499- 506.
  • Barrueco Ferrero, M y cols.; Manual de prevención y tratamiento de tabaquismo.; 3ª ed Ergon 2006.
  • http://www.zerobreastcancer.org/research/cotinina_esp. pdf
  • Pérez, Trullén, A y cols; Tratado de tabaquismo; Capitulo 25, Marcadores biológicos y funcionales para la determinación de exposición de los fumadores; Aula Médica Ediciones, 2004; 302-303, 306-307.
  • Carrión Valero, F; Prevención del tabaquismo, vol 3 nº 1, Marzo 2001; 31-33.